Several studies have been conducted on TMEFF2 in the oncological diseases of the female reproductive system, focusing on the methylation of TMEFF2 in endometrial cancer, high-grade squamous intraepithelial lesions (HSIL), and cervical cancer [44,45]. Here, TMEFF2 is linked to endometrial cancer.